• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC BLUE RHINO G2-MULTI PERCUTANEOUS TRACHEOSTOMY INTRODUCER SET; JOH TUBE TRACHEOSTOMY AND TUBE CUFF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC BLUE RHINO G2-MULTI PERCUTANEOUS TRACHEOSTOMY INTRODUCER SET; JOH TUBE TRACHEOSTOMY AND TUBE CUFF Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Increased Respiratory Rate (2486); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 01/16/2022
Event Type  Injury  
Event Description
As reported in a retrospective, observational, post-market study, a 25-year-old female patient had a left lower lobe infiltrate following a tracheostomy placement procedure.On (b)(6) 2022 (1-day post-procedure), the patient had a left lower lobe infiltrate identified on chest x-ray.The site noted, ¿at the time, patient was afebrile and without leukocytosis.It was unclear whether this represented some degree of aspiration from tracheostomy placement or an evolving pneumonia.¿ the patient then developed a fever and leukocytosis.She also developed tachypnea (present at baseline, but increased) and required frequent suctioning, which contributed to the concern for developing pneumonia.Fio2 requirements were increased on (b)(6) 2022.The patient was started on iv vancomycin and zosyn for suspected hospital-acquired pneumonia, but the culture ultimately came back with normal oral flora.It should also be noted that the site determined that the event was not considered related to the blue rhino device, but that the event was considered related to the study procedure.The patient completed her course of antibiotics on (b)(6) 2022, and no additional adverse effects were reported for the patient.
 
Manufacturer Narrative
Blank fields on this form indicate the information is unknown or unavailable.E3- occupation: principal investigator.G4- pma/510(k) #: k193133.H6-annex e code unavailable: required frequent suctioning.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned or that a death or serious injury occurred; nor is it admission that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Manufacturer Narrative
Blank fields on this form indicate the information is unknown, unavailable, or unchanged.Investigation ¿ evaluation.It was reported that a patient had a left lower lobe infiltrate following a tracheostomy placement procedure with a blue rhino g2-multi percutaneous tracheostomy introducer set.The device was placed due to acute respiratory insufficiency related to traumatic brain injury.On (b)(6) 2022 (1-day post-procedure), the patient had a left lower lobe infiltrate identified on chest x-ray.At this time, it was noted the patient was without fever and without elevated white blood cells.It is unclear if the infiltrate represented some degree of aspiration from tracheostomy placement or an evolving pneumonia.Later, the patient developed a fever, elevated white blood cells, and increased heart rate (present at baseline, but increased).She also required frequent suctioning, which contributed to the concern for developing pneumonia.Fio2 requirements were increased on (b)(6) 2022.The patient was started on intravenous (iv) antibiotics for suspected hospital-acquired pneumonia, but the culture ultimately came back with normal oral flora.The patient completed her course of antibiotics on (b)(6) 2022, and no additional adverse effects were reported.Reviews of quality control and instructions for use (ifu), were conducted during the investigation.The complaint device was not returned; therefore, no physical examinations could be performed.However, a document-based investigation evaluation was performed.A review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify any potential non-conformances prior to distribution.A review of the device history record (dhr) was unable to be completed due to a lack of lot information.An expanded sales search to the customer was unable to identify the complaint lot.Based on the available information, cook has concluded that the device was manufactured to specification and that there is no evidence suggesting nonconforming product exists either in house or in the field.Cook also reviewed product labeling.The most recent instructions for use (ifu) [c_t_ptisg2_rev0] packaged with the device contains the following in relation to the reported failure mode: ¿contraindications: unstable cervical spine fracture.Instructions for use: patient preparation: 2.Place the patient in the tracheostomy position.(fig.4) position a pillow under the shoulders to permit full extension of head and neck.The head of the patient¿s bed may be elevated 30-40 degrees at the physician's discretion.¿ based on the available information, no product returned, and the results of the investigation, cook has concluded that adverse event related to procedure is the cause of this event.It is possible the patient's injury prohibited them from being placed in the tracheostomy position, but cook can not confirm this without more information.It was noted that the site determined that the event was not related to the blue rhino device.The appropriate personnel have been notified.Cook will continue to monitor for similar complaints.Per the risk assessment no further action is required.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BLUE RHINO G2-MULTI PERCUTANEOUS TRACHEOSTOMY INTRODUCER SET
Type of Device
JOH TUBE TRACHEOSTOMY AND TUBE CUFF
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer (Section G)
COOK INC
750 daniels way
bloomington IN 47404
Manufacturer Contact
jason crouch
750 daniels way
bloomington, IN 47404
8123392235
MDR Report Key17273365
MDR Text Key318566686
Report Number1820334-2023-00871
Device Sequence Number1
Product Code JOH
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,User Facility
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/06/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberN/A
Device Catalogue NumberC-PTIS-100-HC-G-NA-FLEX7.5
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received11/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age25 YR
Patient SexFemale
Patient Weight84 KG
-
-